Efficacy Clinical Trial
Official title:
Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.
To evaluate the efficacy and tolerability of Auris-Sedina in the symptomatic control of otalgy in patients with and without acute external otitis compared with use of Otosynalar®.
Phase III open Study, multicenter, prospective, randomized entrance of a total of 188
patients, 94 patients will receive medication test and 94 patients will receive Otosynalar®.
Patients will be assessed until the clinical condition has been resolved or a maximum of 3
days.
188 patients of either gender or race, who have at least two of the following symptoms:
pain, discharge, tinnitus, ear fullness, subjective hearing loss temporary dizziness or
vertigo. And with a clinical or non-acute external otitis.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT00944268 -
Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety
|
Phase 3 | |
| Completed |
NCT00504192 -
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
|
Phase 2 | |
| Recruiting |
NCT05580159 -
New Generation mRNA Booster Vaccine Against Emerging VOCs
|
Phase 3 | |
| Completed |
NCT05427305 -
TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer
|
Phase 3 | |
| Active, not recruiting |
NCT05686161 -
mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs
|
Phase 3 | |
| Recruiting |
NCT06284746 -
Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer
|
Phase 2 | |
| Completed |
NCT04260113 -
Apatinib for Inoperable Advanced Chondrosarcoma
|
N/A | |
| Recruiting |
NCT06120712 -
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04002440 -
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
|
N/A | |
| Recruiting |
NCT02693587 -
Misodel or Angusta for Induction of Labour?
|
N/A | |
| Completed |
NCT01194453 -
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT05276557 -
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
|
Phase 3 | |
| Recruiting |
NCT06205758 -
Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency
|
||
| Recruiting |
NCT06122454 -
A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05913271 -
Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure
|
||
| Recruiting |
NCT05999656 -
Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot
|
N/A | |
| Recruiting |
NCT05731258 -
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
|
||
| Recruiting |
NCT03908138 -
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
|
Phase 4 | |
| Completed |
NCT05648799 -
Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19
|
N/A | |
| Recruiting |
NCT03377933 -
The Effects Probiotic Has on Gastromicroecology and Combined With Quadruple Regimen for H Pylori Infection
|
N/A |